Yuri Misnik is the Chief Technology Officer at inDrive, where he leads the company’s global technology strategy. With more than two decades of international experience, Misnik has built and led ...
Travere Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients aged 8 years and ...
Comparison of fentanyl test strips shows the research team’s enhanced strips (bottom) alongside commercial versions (top). In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results